Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8571 |
High Similarity |
NPD7054 |
Approved |
0.8528 |
High Similarity |
NPD7685 |
Pre-registration |
0.8519 |
High Similarity |
NPD7472 |
Approved |
0.8519 |
High Similarity |
NPD7074 |
Phase 3 |
0.8509 |
High Similarity |
NPD3818 |
Discontinued |
0.8503 |
High Similarity |
NPD7266 |
Discontinued |
0.8476 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8411 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8408 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8364 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8354 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8303 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8228 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8217 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8193 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8163 |
Intermediate Similarity |
NPD1933 |
Approved |
0.8121 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8101 |
Intermediate Similarity |
NPD37 |
Approved |
0.8063 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8063 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8063 |
Intermediate Similarity |
NPD4965 |
Approved |
0.805 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8049 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8039 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7937 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7919 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7917 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7882 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7882 |
Intermediate Similarity |
NPD8313 |
Approved |
0.784 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7826 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.78 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7792 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7785 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7724 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7708 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7707 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7707 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7661 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7658 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7657 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7635 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7616 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7616 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7605 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7593 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.759 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7571 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7484 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7431 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7427 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7405 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7379 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7362 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7362 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7329 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7297 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7294 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7255 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7247 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD919 |
Approved |
0.7211 |
Intermediate Similarity |
NPD17 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7195 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7192 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7166 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7143 |
Intermediate Similarity |
NPD411 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7108 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7068 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD2821 |
Approved |
0.7027 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7006
|
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |